Literature DB >> 26970145

Spontaneous Regeneration of the Mandible: An Institutional Audit of Regenerated Bone and Osteocompetent Periosteum.

Eyituoyo Okoturo1, Olabode V Ogunbanjo2, Godwin T Arotiba3.   

Abstract

PURPOSE: Childhood mandibular lesions are frequently benign; this allows for a conservative surgical approach to their management. Two of the most common approaches for reconstruction of acquired mandibular defects in adolescents are vascularized and nonvascularized osseous flaps or grafts. A third, less commonly used treatment option often used in developing parts of the world that some Western centers are considering as part of their treatment algorithm is spontaneous bone regeneration. This study reports on the authors' experiences with spontaneous bone formation of the resected young mandible. It also attempts to quantify any relation between spontaneous bone regeneration and an aging osteocompetent periosteum. PATIENTS AND METHODS: This was a retrospective study based on consecutive data collated from records of the oral and maxillofacial surgery departments from 2 tertiary institutions. Eligible patients were no older than 18 years and had benign mandibular neoplasms. The surgical procedure was mandibulectomy with subperiosteal dissection and intermaxillary fixation. Regenerated bone evaluation was by clinical examination and periodic panoramic radiographs.
RESULTS: Sixteen consecutive cases with mandibular lesions were seen at the 2 institutions, 8 of which met the inclusion criteria. The average age was 10.75 years. The predominant pathology was unicystic ameloblastoma. All cases exhibited spontaneous bone regeneration, with 2 cases exhibiting "incomplete" bone regeneration.
CONCLUSION: Immediate reconstruction can be delayed to allow for spontaneous bone regeneration of defects in young patients. In the absence of regeneration, secondary reconstruction can be considered. Although the literature reports more young patients with bone regeneration than adults, increasing age during childhood and adolescence might not necessarily indicate a decrease in periosteal bone-regenerating potential.
Copyright © 2016 American Association of Oral and Maxillofacial Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 26970145     DOI: 10.1016/j.joms.2016.02.007

Source DB:  PubMed          Journal:  J Oral Maxillofac Surg        ISSN: 0278-2391            Impact factor:   1.895


  6 in total

1.  Actinomycotic osteomyelitis with proliferative periostitis arising in the mandibular ramus: an unusual case with spontaneous bone regeneration after coronoidectomy.

Authors:  Toshinori Iwai; Nobuhide Ohashi; Satomi Sugiyama; Hiroaki Kitajima; Makoto Hirota; Shoji Yamanaka; Kenji Mitsudo
Journal:  Oral Radiol       Date:  2020-06-30       Impact factor: 1.852

Review 2.  Reassessing the embryonic origin and potential of craniofacial ectomesenchyme.

Authors:  Peter Fabian; J Gage Crump
Journal:  Semin Cell Dev Biol       Date:  2022-03-21       Impact factor: 7.499

3.  Spontaneous bone regeneration in resected non-continuous mandible due to medication-related osteonecrosis of the jaw.

Authors:  Alparslan Esen; Gokhan Gurses; Sebnem Akkulah
Journal:  J Korean Assoc Oral Maxillofac Surg       Date:  2021-12-31

4.  Approach and Treatment of Giant Luminal Unicystic Ameloblastoma.

Authors:  George Borja de Freitas; Evelyne Pedroza de Andrade; Riedel Frota Sá Nogueira Neves; Stefanny Torres Dos Santos; Daniella Cristina da Costa Araújo; Victor Ângelo Montalli
Journal:  Case Rep Dent       Date:  2018-05-30

5.  SP1/TGF‑β1/SMAD2 pathway is involved in angiogenesis during osteogenesis.

Authors:  Ao Ding; Ying-Ying Bian; Zhi-Hong Zhang
Journal:  Mol Med Rep       Date:  2020-01-27       Impact factor: 2.952

Review 6.  Spontaneous regeneration of the mandible following hemimandibulectomy for medication-related osteonecrosis of the jaw: A case report.

Authors:  Shinpei Matsuda; Hisato Yoshida; Minako Shimada; Hitoshi Yoshimura
Journal:  Medicine (Baltimore)       Date:  2020-08-14       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.